These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 27912110)
1. Structures and mechanisms of CRISPR RNA-guided effector nucleases. Nishimasu H; Nureki O Curr Opin Struct Biol; 2017 Apr; 43():68-78. PubMed ID: 27912110 [TBL] [Abstract][Full Text] [Related]
2. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity. Charpentier E; Richter H; van der Oost J; White MF FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611 [TBL] [Abstract][Full Text] [Related]
3. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex. Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008 [TBL] [Abstract][Full Text] [Related]
4. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex. Takeshita D; Sato M; Inanaga H; Numata T J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408 [TBL] [Abstract][Full Text] [Related]
5. Primary processing of CRISPR RNA by the endonuclease Cas6 in Staphylococcus epidermidis. Wakefield N; Rajan R; Sontheimer EJ FEBS Lett; 2015 Oct; 589(20 Pt B):3197-204. PubMed ID: 26364721 [TBL] [Abstract][Full Text] [Related]
6. CRISPR RNA-guided DNA cleavage by reconstituted Type I-A immune effector complexes. Majumdar S; Terns MP Extremophiles; 2019 Jan; 23(1):19-33. PubMed ID: 30284045 [TBL] [Abstract][Full Text] [Related]
7. Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR-Cas system by binding to target RNA and crRNA. Li Y; Zhang Y; Lin J; Pan S; Han W; Peng N; Liang YX; She Q Nucleic Acids Res; 2017 Nov; 45(19):11305-11314. PubMed ID: 28977458 [TBL] [Abstract][Full Text] [Related]
8. Molecular architectures and mechanisms of Class 2 CRISPR-associated nucleases. Garcia-Doval C; Jinek M Curr Opin Struct Biol; 2017 Dec; 47():157-166. PubMed ID: 29107822 [TBL] [Abstract][Full Text] [Related]
9. Type III CRISPR-Cas Immunity: Major Differences Brushed Aside. Tamulaitis G; Venclovas Č; Siksnys V Trends Microbiol; 2017 Jan; 25(1):49-61. PubMed ID: 27773522 [TBL] [Abstract][Full Text] [Related]
10. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii. Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147 [TBL] [Abstract][Full Text] [Related]
11. Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases. Walker FC; Chou-Zheng L; Dunkle JA; Hatoum-Aslan A Nucleic Acids Res; 2017 Feb; 45(4):2112-2123. PubMed ID: 28204542 [TBL] [Abstract][Full Text] [Related]
12. Type IV CRISPR RNA processing and effector complex formation in Aromatoleum aromaticum. Özcan A; Pausch P; Linden A; Wulf A; Schühle K; Heider J; Urlaub H; Heimerl T; Bange G; Randau L Nat Microbiol; 2019 Jan; 4(1):89-96. PubMed ID: 30397343 [TBL] [Abstract][Full Text] [Related]
13. Altered stoichiometry Escherichia coli Cascade complexes with shortened CRISPR RNA spacers are capable of interference and primed adaptation. Kuznedelov K; Mekler V; Lemak S; Tokmina-Lukaszewska M; Datsenko KA; Jain I; Savitskaya E; Mallon J; Shmakov S; Bothner B; Bailey S; Yakunin AF; Severinov K; Semenova E Nucleic Acids Res; 2016 Dec; 44(22):10849-10861. PubMed ID: 27738137 [TBL] [Abstract][Full Text] [Related]
14. Highly efficient primed spacer acquisition from targets destroyed by the Escherichia coli type I-E CRISPR-Cas interfering complex. Semenova E; Savitskaya E; Musharova O; Strotskaya A; Vorontsova D; Datsenko KA; Logacheva MD; Severinov K Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7626-31. PubMed ID: 27325762 [TBL] [Abstract][Full Text] [Related]